Search Results - "Qiaorui TAN"
-
1
Potential Predictive and Prognostic Value of Biomarkers Related to Immune Checkpoint Inhibitor Therapy of Triple-Negative Breast Cancer
Published in Frontiers in oncology (29-04-2022)“…As an aggressive subtype of breast cancer, triple-negative breast cancer (TNBC) is associated with poor prognosis and lack of effective therapy, except…”
Get full text
Journal Article -
2
Potential predictive value of circulating tumor DNA (ctDNA) mutations for the efficacy of immune checkpoint inhibitors in advanced triple-negative breast cancer
Published in Frontiers in genetics (16-03-2023)“…In recent years, tumor immunotherapy has become a viable treatment option for triple negative breast cancer (TNBC). Among these, immune checkpoint inhibitors…”
Get full text
Journal Article -
3
The Therapeutic Effectiveness of Neoadjuvant Trastuzumab Plus Chemotherapy for HER2-Positive Breast Cancer Can Be Predicted by Tumor-Infiltrating Lymphocytes and PD-L1 Expression
Published in Frontiers in oncology (05-01-2022)“…Neoadjuvant trastuzumab plus chemotherapy may affect programmed death-ligand 1 (PD-L1) expression and tumor-infiltrating lymphocytes (TILs) in HER2-positive…”
Get full text
Journal Article -
4
Efficacy and safety of pyrotinib‐containing regimen in the patients with HER2‐positive metastatic breast cancer: A multicenter real‐world study
Published in Cancer medicine (Malden, MA) (01-02-2023)“…Background Pyrotinib, a novel irreversible epidermal growth factor receptor 2 (EGFR)/HER2 dual tyrosine kinase inhibitor, has shown promising antitumor…”
Get full text
Journal Article -
5
The metastasis patterns and their prognostic features in patients with de novo metastatic breast cancer of different ages
Published in Cancer medicine (Malden, MA) (01-09-2023)“…Purpose The prognostic outcomes of metastasis patterns in patients with de novo metastatic breast cancer (dnMBC) of different ages are unknown. Our study used…”
Get full text
Journal Article -
6
Lithospermic acid improves liver fibrosis through Piezo1-mediated oxidative stress and inflammation
Published in Phytomedicine (Stuttgart) (01-11-2024)“…•Lithospermic acid (LA) improved carbon tetrachloride (CCl4) induced liver fibrosis.•LA significantly decreased Piezo1 expression and inhibited macrophage…”
Get full text
Journal Article -
7
Abstract P1-08-27: Dynamic monitoring of circulating tumor DNA can predict chemotherapy response and prognosis in metastatic triple-negative breast cancer patients
Published in Cancer research (Chicago, Ill.) (15-02-2022)“…Abstract Background: Chemotherapy is the main treatment for metastatic triple-negative breast cancer (mTNBC). However, mTNBC patients (pts) is often associated…”
Get full text
Journal Article -
8
miR‑149‑5p inhibition reduces Alzheimer's disease β‑amyloid generation in 293/APPsw cells by upregulating H4K16ac via KAT8
Published in Experimental and therapeutic medicine (01-11-2020)“…Alzheimer's disease (AD), the leading cause of age-related dementia, is characterized by abnormal β-amyloid accumulation. During learning, memory formation and…”
Get full text
Journal Article -
9
Effectiveness and Safety of Pyrotinib-Based Therapy in the Treatment of HER2-Positive Breast Cancer Patients with Brain Metastases: A Multicenter Real-World Study
Published in Clinical breast cancer (01-08-2024)“…Approximately 30% to 50% of patients with human epidermal growth factor receptor 2-positive metastatic breast cancer develop brain metastasis (BMs). Pyrotinib…”
Get full text
Journal Article -
10
Piezo1 specific deletion in macrophage protects the progression of liver fibrosis in mice
Published in Theranostics (01-01-2023)“…Background and Aims: Liver fibrosis is the common pathological pathway of chronic liver diseases and its mechanisms of which have not been fully declared…”
Get full text
Journal Article -
11
Abstract P3-05-31: PVT1, CASC16, TNFRSF13B and NAMPT may be the key genes correlated with recurrence and metastasis of breast cancer
Published in Cancer research (Chicago, Ill.) (01-03-2023)“…Abstract Background: It is vital to find the risk genes and loci related to recurrence and metastasis in breast cancer (BC) patients. The Genome-wide…”
Get full text
Journal Article -
12
miR-149-5p inhibition reduces Alzheimer's disease [beta]-amyloid generation in 293/APPsw cells by upregulating H4K16ac via KAT8
Published in Experimental and therapeutic medicine (01-11-2020)“…Alzheimer's disease (AD), the leading cause of age-related dementia, is characterized by abnormal [beta]-amyloid accumulation. During learning, memory…”
Get full text
Journal Article -
13
Abstract P1-14-03: Efficacy and safety of pyrotinib-based therapy in the treatment of HER2-positive breast cancer patients with brain metastases:a multi-center real-world study
Published in Cancer research (Chicago, Ill.) (01-03-2023)“…Abstract Background: An estimated 30-50% of patients with human epidermal growth factor receptor 2 (HER2)-positive metastatic breast cancer (MBC) will develop…”
Get full text
Journal Article -
14
Survival analysis and nomogram for early-stage occult breast cancer with positive lymph nodes based on the SEER database
Published in Annals of translational medicine (01-12-2022)“…Occult breast cancer (OBC) is a rare type of breast cancer, which accounts for 0.3-1.0% of all breast cancers. However, the treatment of OBC remains…”
Get full text
Journal Article -
15
Abstract PO4-04-07: Efficacy, safety and translational study of pyrotinib combined with albumin-bound paclitaxel as firstline treatment of HER-2 positive metastatic breast cancer
Published in Cancer research (Chicago, Ill.) (02-05-2024)“…Abstract Objective: Breast Cancer is one of the most common malignant tumors in women. HER-2 is a driver gene for poor prognosis in breast cancer. Anti-HER-2…”
Get full text
Journal Article -
16
Abstract OT1-05-02: Efficacy and safety of sintilimab in combination with anlotinib plus metronomic chemotherapy in advanced triple negative breast cancer (SPACE): preliminary results of a single-arm, multicenter phase II trial
Published in Cancer research (Chicago, Ill.) (01-03-2023)“…Abstract Background: Anti-PD-1 antibody combined with antiangiogenic drugs have demonstrated antitumor activity in advanced triple negative breast cancer…”
Get full text
Journal Article -
17
The mechanisms by which Yiqi Huoxue compound treats pulmonary inflammation and fibrosis in scleroderma: Based on bioinformatics and network pharmacology
Published in Pifu-xingbing zhenliaoxue zazhi (01-05-2024)“…Objective To identify the effective components and key molecules of Yiqi Huoxu compound(YQHX) in the treatment of pulmonary inflammation and fibrosis in…”
Get full text
Journal Article